ID | Term | Allele | Alleles | Background | Color Key |
---|
MP:0001828 | abnormal T cell activation |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | either: (involves: 129S2/SvPas) or (involves: 129S1/Sv * 129X1/SvJ) | color key |
MP:0008088 | abnormal T-helper 1 cell differentiation |
Mapk9tm1Flv |
Mapk9tm1Flv/Mapk9tm1Flv | involves: 129S2/SvPas | color key |
MP:0005584 | abnormal enzyme/coenzyme activity |
Mapk9tm1Flv |
Mapk9tm1Flv/Mapk9tm1Flv | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0002912 | abnormal excitatory postsynaptic potential |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | either: (involves: 129S2/SvPas * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) | color key |
MP:0002656 | abnormal keratinocyte differentiation |
Mapk9tm1Flv |
Mapk9tm1Flv/Mapk9tm1Flv | B6.129S2-Mapk9 | color key |
MP:0002655 | abnormal keratinocyte morphology |
Mapk9tm1Flv |
Mapk9tm1Flv/Mapk9tm1Flv | B6.129S2-Mapk9 | color key |
MP:0000609 | abnormal liver physiology |
Mapk9tm1Flv |
Mapk9tm1Flv/Mapk9tm1Flv | B6.129S2-Mapk9/J | color key |
MP:0005329 | abnormal myocardium layer morphology |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | involves: 129/Sv * C57BL/6 | color key |
MP:0005445 | abnormal neurotransmitter secretion |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | either: (involves: 129S2/SvPas * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) | color key |
MP:0008872 | abnormal physiological response to xenobiotic |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | B6.129-Mapk9 | color key |
MP:0006414 | decreased T cell apoptosis |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | either: (involves: 129S2/SvPas) or (involves: 129S1/Sv * 129X1/SvJ) | color key |
MP:0005095 | decreased T cell proliferation |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | either: (involves: 129S2/SvPas) or (involves: 129S1/Sv * 129X1/SvJ) | color key |
MP:0003223 | decreased cardiomyocyte apoptosis |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | involves: 129/Sv * C57BL/6 | color key |
MP:0002920 | decreased paired-pulse facilitation |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | either: (involves: 129S2/SvPas * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) | color key |
MP:0002922 | decreased post-tetanic potentiation |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | either: (involves: 129S2/SvPas * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) | color key |
MP:0009764 | decreased sensitivity to induced morbidity/mortality |
Mapk9tm1Flv |
Mapk9tm1Flv/Mapk9tm1Flv | B6.129S2-Mapk9/J | color key |
MP:0005166 | decreased susceptibility to injury |
Mapk9tm1Flv |
Mapk9tm1Flv/Mapk9tm1Flv | B6.129S2-Mapk9/J | color key |
MP:0001222 | epidermal hyperplasia |
Mapk9tm1Flv |
Mapk9tm1Flv/Mapk9tm1Flv | B6.129S2-Mapk9 | color key |
MP:0001473 | reduced long term potentiation |
Mapk9tm1Mka |
Mapk9tm1Mka/Mapk9tm1Mka | either: (involves: 129S2/SvPas * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) | color key |
MP:0001219 | thick epidermis |
Mapk9tm1Flv |
Mapk9tm1Flv/Mapk9tm1Flv | B6.129S2-Mapk9 | color key |